arginyl-glycyl-aspartyl-serine has been researched along with Kidney Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, I; Murata, J; Saiki, I; Yoneda, J | 1 |
1 other study(ies) available for arginyl-glycyl-aspartyl-serine and Kidney Neoplasms
| Article | Year |
|---|---|
Differences in chemotaxis to fibronectin in weakly and highly metastatic tumor cells.
Topics: Antibodies, Monoclonal; Carcinoma, Renal Cell; Cell Movement; Chemotaxis; Fibronectins; Humans; Intercellular Signaling Peptides and Proteins; Kidney Neoplasms; Melanoma, Experimental; Oligopeptides; Peptides; Receptors, Fibronectin; Tumor Cells, Cultured | 1992 |